Invention Grant
- Patent Title: Bupropion as a modulator of drug activity
-
Application No.: US15691549Application Date: 2017-08-30
-
Publication No.: US10064857B2Publication Date: 2018-09-04
- Inventor: Herriot Tabuteau
- Applicant: ANTECIP BIOVENTURES II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: Maschoff Brennan Laycock Gilmore
- Agent Brent A. Johnson; Yuefen Zhou
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A61K31/44 ; A61K31/485 ; A61K9/00 ; A61K31/137 ; A61K31/138 ; A61K31/4748
Abstract:
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Public/Granted literature
- US20170360774A1 BUPROPION AS A MODULATOR OF DRUG ACTIVITY Public/Granted day:2017-12-21
Information query
IPC分类:
